Magneto-aerotactic bacteria deliver drug-containing nanoliposomes to tumour hypoxic regions
Source abstract
Abstract
Oxygen-depleted hypoxic regions in the tumour are generally resistant to therapies. Although nanocarriers have been used to deliver drugs, the targeting ratios have been very low. Here, we show that the magneto-aerotactic migration behaviour of magnetotactic bacteria, Magnetococcus marinus strain MC-1 (ref. 4), can be used to transport drug-loaded nanoliposomes into hypoxic regions of the tumour. In their natural environment, MC-1 cells, each containing a chain of magnetic iron-oxide nanocrystals, tend to swim along local magnetic field lines and towards low oxygen concentrations based on a two-state aerotactic sensing system. We show that when MC-1 cells bearing covalently bound drug-containing nanoliposomes were injected near the tumour in severe combined immunodeficient beige mice and magnetically guided, up to 55% of MC-1 cells penetrated into hypoxic regions of HCT116 colorectal xenografts. Approximately 70 drug-loaded nanoliposomes were attached to each MC-1 cell. Our results suggest that harnessing swarms of microorganisms exhibiting magneto-aerotactic behaviour can significantly improve the therapeutic index of various nanocarriers in tumour hypoxic regions.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Geomagnetism and Paleomagnetism Studies · Micro and Nano Robotics · Protist diversity and phylogeny
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (26)
Show source-provided references
1. Vaupel, P. & Mayer, A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 26, 225–239 (2007).10.1007/s10555-007-9055-1 ↗
2. Frankel, R. B., Bazylinski, D. A., Johnson, M. S. & Taylor, B. L. Magneto-aerotaxis in marine coccoid bacteria. Biophys. J. 73, 994–1000 (1997).10.1016/S0006-3495(97)78132-3 ↗
3. Blakemore, R. P. Magnetotactic bacteria. Science 190, 377–379 (1975).10.1126/science.170679 ↗
4. Bazilinski, D. A. et al. Magnetococcus marinus gen. nov., sp. nov., a marine, magnetotactic bacterium that represents a novel lineage (Magnetococcaceae fam. nov., Magnetococcales ord. nov.) at the base of the Alphaproteobacteria. Int. J. Syst. Evol. Microbiol. 63, 801–808 (2013).10.1099/ijs.0.038927-0 ↗
5. Bazylinski, D. A., Frankel, R. B. & Jannasch, H. W. Anaerobic magnetite production by a marine, magnetotactic bacterium. Nature 334, 518–519 (1988).10.1038/334518a0 ↗
6. Lefèvre, C. T. et al. Diversity of magneto-aerotactic behaviors and oxygen sensing mechanisms in cultured magnetotactic bacteria. Biophys. J. 107, 527–538 (2014).10.1016/j.bpj.2014.05.043 ↗
7. Brown, J. M. & Wilson, W. R. Exploiting tumour hypoxia in cancer treatment. Nature Rev. 4, 437–446 (2004).
8. Wilson, W. R. & Hay, M. P. Targeting hypoxia in cancer therapy. Nature Rev. Cancer 11, 393–410 (2011).10.1038/nrc3064 ↗
9. Hong, M., Zhu, S., Jiang, Y., Tang, G. & Pei, Y. Efficient tumor targeting of hydroxycamptothecin loaded PEGylated liposomes modified with transferrin. J. Control. Rel. 133, 96–102 (2009).10.1016/j.jconrel.2008.09.005 ↗
10. Tannock, I. F., Lee, C. M., Tunggal, J. K., Cowan, D. S. M. & Egorin, M. J. Limited penetration of anticancer drugs through tumor tissue. Clin. Cancer Res. 8, 878–884 (2002).
11. Patyar, S. et al. Bacteria in cancer therapy: a novel experimental strategy. J. Biomed. Sci. 17, 21 (2010).10.1186/1423-0127-17-21 ↗
12. Schüler, D. Formation of magnetosomes in magnetotactic bacteria. J. Molec. Microbiol. Biotechnol. 1, 79–86 (1999).
13. de Lanauze, D., Felfoul, O., Turcot, J.-P., Mohammadi, M. & Martel, S. Three-dimensional remote aggregation and steering of magnetotactic bacteria microrobots for drug delivery applications. Int. J. Robot. Res. 33, 359–374 (2014).10.1177/0278364913500543 ↗
14. McDonald, D. M. & Baluk, P. Significance of blood vessel leakiness in cancer. Cancer Res. 62, 5381–5385 (2002).
15. Heldin, C.-H., Rubin, K., Pietras, K. & Ostman, A. High interstitial fluid pressure—an obstacle in cancer therapy. Nature Rev. Cancer 4, 806–813 (2004).10.1038/nrc1456 ↗
16. Taherkhani, S., Mohammadi, M., Daoud, J., Martel, S. & Tabrizian, M. Covalent binding of nanoliposomes to the surface of magnetotactic bacteria acting as self-propelled target delivery agents. ACS Nano 8, 5049–5060 (2014).10.1021/nn5011304 ↗
17. Danhier, F., Feron, O. & Préat, V. To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery. J. Control Rel. 148, 135–146 (2010).10.1016/j.jconrel.2010.08.027 ↗
18. Harrison, L. B., Chadha, M., Hill, R. J., Hu, K. & Shasha, D. Impact of tumor hypoxia and anemia on radiation therapy outcomes. Oncologist 7, 492–508 (2002).10.1634/theoncologist.7-6-492 ↗
19. Moeller, B. J., Richardson, R. A. & Dewhirst, M. W. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment. Cancer Metastasis Rev. 26, 241–248 (2007).10.1007/s10555-007-9056-0 ↗
20. Polyak, B. & Friedman, G. Magnetic targeting for site-specific drug delivery: applications and clinical potential. Expert Opin. Drug Delivery 6, 53–70 (2009).10.1517/17425240802662795 ↗
21. Rotariu, O. & Strachan, N. J. C. Modelling magnetic carrier particle targeting in the tumor microvasculature for cancer treatment. J. Magn. Magn. Mater. 293, 639–646 (2005).10.1016/j.jmmm.2005.01.081 ↗
22. Martel, S. et al. Automatic navigation of an untethered device in the artery of a living animal using a conventional clinical magnetic resonance imaging system. Appl. Phys. Lett. 90, 114105 (2007).10.1063/1.2713229 ↗
23. Dreyfus, R. et al. Microscopic artificial swimmers. Nature 437, 862–865 (2005).10.1038/nature04090 ↗
24. Akin, D. et al. Bacteria-mediated delivery of nanoparticles and cargo into cells. Nature Nanotech. 2, 441–449 (2007).10.1038/nnano.2007.149 ↗
25. Jain, R. K. & Forbes, N. S. Can engineered bacteria help control cancer? Proc. Natl Acad. Sci. USA 98, 14748–14750 (2001).10.1073/pnas.261606598 ↗
26. Schübbe, S. et al. Complete genome sequence of the chemolithoautotrophic marine magnetotactic coccus strain MC-1. Appl. Environ. Microbiol. 75, 4835–4852 (2009).10.1128/AEM.02874-08 ↗